Daily News for Dealmakers
2021 brought a flurry of #MnA activity in the life sciences sector, followed by a slowdown in 2022. Here’s why dealmaking could pick up again. deloi.tt/3PIOHZP
– Deloitte M&A (@DeloitteMnA)09:00 – Aug 31, 2022
AbbVie's recent acquisition of Gilgamesh Pharmaceuticals' psychedelic depression treatment for up to $1.2 billion represents a pivotal moment in the pharmaceutical giant's post-Humira...
Hims & Hers Health's planned 2026 Canadian expansion represents a pivotal strategic shift, combining its recent acquisition of European digital health platform ZAVA with the anticipated launch of...
The pharmaceutical industry witnessed a landmark transaction on July 9, 2025, as Merck & Co. announced its definitive agreement to acquire Verona Pharma for approximately $10 billion, securing...
In a landmark transaction reshaping India's pharmaceutical landscape, Torrent Pharmaceuticals announced the acquisition of KKR's 46.39% controlling stake in JB Chemicals & Pharmaceuticals for...